Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Comparison to BPC-157 While BPC-157 focuses on the blood vessels and the supply lines, TB-500 focuses on the cellular workers themselves
BPC-157, derived from a protective protein in gastric juice, and TB-500, a synthetic fragment of Thymosin Beta-4, have both been investigated for their potential roles in healing, tissue repair, and cellular regeneration
Purity: Refer to batch-specific Certificate of Analysis (COA)
This educational protocol presents a once-daily subcutaneous approach using a practical dilution for clear insulin-syringe measurements
Angiogenic and growth-factor signaling In rat models of muscle and tendon injury, BPC-157 administration has been associated with up-regulated VEGF expression and accelerated formation of granulation tissue and new microvasculature relative to controls (Brcic et al., 2009
